Taro Pharmaceutical
TARO
#5055
Rank
NZ$2.79 B
Marketcap
NZ$74.38
Share price
0.00%
Change (1 day)
9.34%
Change (1 year)

Taro Pharmaceutical (TARO) - Net assets

Net assets on the balance sheet as of December 2023 : NZ$3.07 Billion

According to Taro Pharmaceutical's latest financial reports the company has NZ$3.07 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Taro Pharmaceutical - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2023-03-31$NZ$2.76 B11.97%
2022-03-31$NZ$2.46 B1.66%
2021-03-31$NZ$2.42 B-31.52%
2020-03-31$NZ$3.54 B26.58%
2019-03-31$NZ$2.80 B-8.32%
2018-03-31$NZ$3.05 B3.31%
2017-03-31$NZ$2.95 B5.64%
2016-03-31$NZ$2.79 B47.03%
2015-03-31$NZ$1.90 B61.85%
2014-03-31$NZ$1.17 B10.59%
2013-03-31$NZ$1.06 B
2011-12-31$NZ$0.73 B46.81%
2010-12-31$NZ$0.49 B22.42%
2009-12-31$NZ$0.40 B43.87%
2008-12-31$NZ$0.28 B41.45%
2007-12-31$NZ$0.20 B183.1%
2006-12-31$NZ$70.66 M-62.29%
2005-12-31$NZ$0.18 B-63.75%
2004-12-31$NZ$0.51 B-3.76%
2003-12-31$NZ$0.53 B3.98%
2002-12-31$NZ$0.51 B-2.13%
2001-12-31$NZ$0.52 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
NZ$161.14 B 5,132.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$89.85 B 2,817.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$137.22 B 4,356.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$12.55 B 307.74%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$36.65 B 1,090.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
NZ$77.46 B 2,415.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland